SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016685
Filing Date
2023-05-02
Accepted
2023-05-02 16:13:35
Documents
76
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20230331.htm   iXBRL 10-Q 3229897
2 EX-10.1 dvax-ex10_1.htm EX-10 107636
3 EX-31.1 dvax-ex31_1.htm EX-31 17794
4 EX-31.2 dvax-ex31_2.htm EX-31 17435
5 EX-32.1 dvax-ex32_1.htm EX-32 11089
6 EX-32.2 dvax-ex32_2.htm EX-32 11518
  Complete submission text file 0000950170-23-016685.txt   12642479

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20230331_cal.xml EX-101.CAL 65195
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20230331.xsd EX-101.SCH 86972
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20230331_def.xml EX-101.DEF 349163
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20230331_pre.xml EX-101.PRE 509630
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20230331_lab.xml EX-101.LAB 663752
70 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20230331_htm.xml XML 2589858
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 23879135
SIC: 2834 Pharmaceutical Preparations